DNDN chart looks OK.. but I'm more interested in the FDA approval of Provenge.. coming soon (May 1st deadline):
Might want to try a ratio strangle (maybe 2:1 or 3:2 bullish tilt) on this one because it could go either way.
Saturday, January 2, 2010
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment